Last reviewed · How we verify
NCT05751057: TITAN-MRI
The Role of Cardiovascular Magnetic Resonance in Patients With Non-ST- Elevation- Myocardial Infarction
NA trial testing Cardiovascular Magnetic Resonance in Non-ST Elevation Myocardial Infarction (NSTEMI) in 120 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Cardiocentro Ticino |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 120 |
| Start date | 14 December 2022 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Cardiovascular Magnetic Resonance
Conditions studied
- Non-ST Elevation Myocardial Infarction (NSTEMI) — all drugs for Non-ST Elevation Myocardial Infarction (NSTEMI) →
Sponsor
Cardiocentro Ticino — full company profile →
Who can join
18 and older, any sex, with Non-ST Elevation Myocardial Infarction (NSTEMI). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this prospective study is to evaluate the role of cardiovascular magnetic resonance (CMR) in patients with suspected non-ST elevation myocardial infarction (NSTEMI). The main endpoint is the reclassification rate, defined as the number of patients in whom the information provided by pre-angiography CMR affects the revascularization strategy or the final diagnosis. Participants will undergo to CMR before invasive coronary angiography (ICA).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05751057
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cardiovascular Magnetic Resonance
Trials testing the same drug.
- NCT03862235 — Decreased T1 Times and Impaired Myocardial Contractility in Anabolic Androgenic Steroids Users · completed
- NCT04281823 — DeBakey Cardiovascular Magnetic Resonance Study · recruiting
Other Cardiocentro Ticino trials
Trials by the same sponsor.
- NCT07514962 — Minimally Invasive Coronary Artery Bypass Supported by Cangrelor · recruiting
- NCT05674630 — Ticin for the Treatment of Coronary Lesions With Drug Eluting Ballons · Phase 4 · recruiting
- NCT05696873 — CoPing strategIes-psyChological flexibiliTy in Patients Hospitalized for Ischemic cardiovascUlaR disEase (PICTURE) · recruiting
- NCT04164329 — Anesthetic Neurotoxicity: the Association Between General Anesthesia and the Level of Plasma Neurofilament Light · unknown
- NCT04761068 — Clinical Outcomes of Patients Undergoing CABG Surgery With VEST Supported Venous Grafts · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05751057 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardiocentro Ticino
- Last refreshed: 2 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05751057.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing